IRIS
BATTISTA, TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 507
NA - Nord America 415
AS - Asia 227
AF - Africa 25
OC - Oceania 1
Totale 1.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 408
DE - Germania 399
SG - Singapore 178
IT - Italia 59
CI - Costa d'Avorio 25
CN - Cina 21
IN - India 19
FI - Finlandia 17
ES - Italia 7
GB - Regno Unito 5
RS - Serbia 5
FR - Francia 4
IE - Irlanda 4
JP - Giappone 4
MX - Messico 4
NL - Olanda 4
CA - Canada 3
BE - Belgio 2
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
PL - Polonia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.175
Salva come PNG Salva come JPEG
Città #
Singapore 150
Krefeld 111
Santa Clara 79
Chandler 74
Ashburn 45
Bad Bellingen 42
Lappeenranta 14
Naples 10
Pune 10
Los Angeles 8
Rome 8
Milan 7
Karlsruhe 5
Amsterdam 4
Dublin 4
Kochi 4
Mexico City 4
Seattle 4
Tokyo 4
Xi'an 4
Zhengzhou 4
Bad Durrheim 3
Boston 3
Edinburgh 3
Freiburg im Breisgau 3
Helsinki 3
Kronberg 3
Lawrence 3
New York 3
Nuremberg 3
Paris 3
Rietheim-Weilheim 3
Roccasecca 3
Rottweil 3
Bhundsi 2
Boardman 2
Bolzano 2
Brussels 2
Chennai 2
Frankfurt am Main 2
Millbury 2
Mozzagrogna 2
Pescara 2
San Nicola la Strada 2
Schoenwalde 2
Shenzhen 2
Turin 2
Angri 1
Bad Krozingen 1
Belgrade 1
Boulder 1
Caivano 1
Camisano Vicentino 1
Chicago 1
Cologne 1
Dallas 1
Delhi 1
Denver 1
Dubai 1
Elora 1
Florence 1
Harbin 1
Kunming 1
London 1
Mariglianella 1
Montecorvino Rovella 1
Munich 1
Perth 1
Richmond 1
Rozzano 1
Salt Lake City 1
Seville 1
Slough 1
Tashkent 1
Temecula 1
Victoria 1
Warsaw 1
Washington 1
Wilmington 1
Yinchuan 1
Totale 693
Salva come PNG Salva come JPEG
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 324
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 44
An uncommon case of lichen spinulosus induced by dupilumab in a patient treated for bronchial asthma 30
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis 29
Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report 27
Alopecia Areata after COVID-19 Vaccines 26
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 26
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 25
COVID-19 and cutaneous manifestations: A review of the published literature 22
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 22
A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab 22
COVID-19 vaccination and inflammatory skin diseases 22
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 21
Real-world practice indirect comparison between guselkumab, risankizumab and tildrakizumab: results from an Italian 28-week retrospective study 21
Pemphigus Vulgaris and COVID-19 vaccination: Management and Treatment 20
Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors 19
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 19
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 19
Leg paralysis after photodynamic therapy for Lymphomatoid Papulosis: a case report 19
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics 19
Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study 18
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab" 17
Epidermolysis bullosa: new insights for the future 16
Bullous pemphigoid and COVID ‐19 vaccination: management and treatment Reply to ‘Bullous pemphigoid in a young male after COVID ‐19 mRNA vaccine: a report and brief literature review’ by Pauluzzi et al 16
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data 16
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis 16
Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study 16
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 16
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 15
Comment on: "Associations between hidradenitis suppurativa and dermatological conditions in adults: A national cross-sectional study by Brown et al." 15
Reply to “Nail psoriasis: a rare mRNA COVID ‐19 vaccine reaction” by Lamberti A et al 15
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis 14
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 14
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa' 14
Risk Factors for Psoriasis Flares: A Narrative Review 13
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials 12
Dupilumab for the treatment of adult atopic dermatitis in special populations 12
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 12
Atypical case of cutaneous Rosai-Dorfman disease 12
Comment on 'Morphoea following COVID-19 vaccination' 12
Comment on ‘Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine’ 11
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? 11
Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa” 11
Advancing Dermatology: Embracing the Power of Artificial Intelligence 11
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature 10
Guselkumab-induced vitiligo in a patient with psoriatic arthritis 9
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19 9
Comment on ‘Anogenital dermatology: challenges in the digital era’ 9
Allergic contact dermatitis to petrolatum: An unknown for patch testing 8
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review 8
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report 8
Comment on ‘Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease’ 8
Management of Psoriasis Patients with Serious Infectious Diseases 7
Comment on ‘Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination’ 7
Reply to “Dalbavancin for the treatment of severe hidradenitis suppurativa” 7
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study 6
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 6
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments 5
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report 5
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature 3
The impact of tildrakizumab on quality of life in patients suffering from moderate-to-severe psoriasis: a 36-week prospective, monocentric, real-life, observational study 3
Reply to ‘Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa’ by Holgersen et al 1
Totale 1.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 1 0 1 2 5
2022/2023284 4 16 3 15 35 29 13 40 37 18 33 41
2023/2024657 11 41 49 22 13 28 10 50 316 16 60 41
2024/2025280 77 92 15 12 84 0 0 0 0 0 0 0
Totale 1.230